Monoclonal Gammopathy in Systemic Lupus Erythematosus
- 1 August 1992
- journal article
- Published by SAGE Publications in Lupus
- Vol. 1 (4) , 263-264
- https://doi.org/10.1177/096120339200100410
Abstract
In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstrating a higher incidence of MG in SLE patients in comparison with the general population. Neither the clinical importance nor the pathogenetic significance of this association is known.Keywords
This publication has 10 references indexed in Scilit:
- Monoclonal gammopathies—their identification and biological significanceClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Systemic Lupus Erythematosus and Monoclonal GammopathyRheumatology, 1988
- RHEUMATOLOGICAL DISORDERS AND MONOCLONAL GAMMOPATHY—A NEW SYNDROME?Rheumatology, 1987
- Anaplastic myeloma in systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1984
- Systemic lupus erythematosus with paraproteinemiaArthritis & Rheumatism, 1984
- Discoid lupus erythematosus and monoclonal gammopathyBritish Journal of Dermatology, 1983
- Monoclonal gammopathies in the adult population of Finistère, France.Journal of Clinical Pathology, 1982
- Incidence of Monoclonal Proteins in a Minnesota Community With a Cluster of Multiple MyelomaBlood, 1972
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966